US Military Embedded Systems Market

ID: MRFR/AD/19294-HCR
100 Pages
Abbas Raut
Last Updated: April 06, 2026
US Military Embedded Systems Market Size, Share, Industry Trend & Analysis Research Report: By Component (Hardware, Software), By Product Type (Advanced Telecom Computing Architecture (TCA), Compact-PCI (CPCI) Boards, Compact-PCI (CPCI) Serial, VME BUS, OPEN VPX, Motherboard, Others), By Application (Intelligence Surveillance and Reconnaissance (ISR), Command, Control, Communication & Navigation, Radar, Avionics, Vetronics, Cyber, Networking, Others) andBy Platform (Land, Airborne, Marine, Space)- Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Military Embedded Systems Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)6.03%
2024 Market Size$ 4,200 Million
2025 Market Size$ 4,453.26 Million
2035 Market Size$ 8,000 Million

Key Players

Lockheed Martin
Raytheon Technologies
Northrop Grumman
General Dynamics
BAE Systems
Thales Group
Trends
  • Integration of Artificial Intelligence
  • Shift Towards Open Architecture
  • Focus on Cybersecurity
Opportunities
  • Increased Defense Budgets
  • Advancements in Sensor Technology
  • Emphasis on Real-Time Data Processing
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Component (USD Million)
      1. 4.1.1 Hardware
      2. 4.1.2 Software
    2. 4.2 Pharmaceutical, BY Product Type (USD Million)
      1. 4.2.1 Advanced Telecom Computing Architecture (TCA)
      2. 4.2.2 Compact-PCI (CPCI) Boards
      3. 4.2.3 Compact-PCI (CPCI) Serial
      4. 4.2.4 VME BUS
      5. 4.2.5 OPEN VPX
      6. 4.2.6 Motherboard
      7. 4.2.7 Others
    3. 4.3 Pharmaceutical, BY Application (USD Million)
      1. 4.3.1 Intelligence Surveillance and Reconnaissance (ISR)
      2. 4.3.2 Command, Control, Communication & Navigation
      3. 4.3.3 Radar
      4. 4.3.4 Avionics
      5. 4.3.5 Vetronics
      6. 4.3.6 Cyber
      7. 4.3.7 Networking
      8. 4.3.8 Others
    4. 4.4 Pharmaceutical, BY Platform (USD Million)
      1. 4.4.1 Land
      2. 4.4.2 Airborne
      3. 4.4.3 Marine
      4. 4.4.4 Space
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Lockheed Martin (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Raytheon Technologies (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Northrop Grumman (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 General Dynamics (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 BAE Systems (GB)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Thales Group (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Leonardo (IT)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 L3Harris Technologies (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Elbit Systems (IL)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY COMPONENT
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY APPLICATION
    5. 6.5 US MARKET ANALYSIS BY PLATFORM
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY COMPONENT, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY COMPONENT, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY PLATFORM, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY PLATFORM, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY COMPONENT, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
      4. 7.2.4 BY PLATFORM, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Pharmaceutical Market Segmentation

Pharmaceutical By Component (USD Million, 2025-2035)

  • Hardware
  • Software

Pharmaceutical By Product Type (USD Million, 2025-2035)

  • Advanced Telecom Computing Architecture (TCA)
  • Compact-PCI (CPCI) Boards
  • Compact-PCI (CPCI) Serial
  • VME BUS
  • OPEN VPX
  • Motherboard
  • Others

Pharmaceutical By Application (USD Million, 2025-2035)

  • Intelligence Surveillance and Reconnaissance (ISR)
  • Command, Control, Communication & Navigation
  • Radar
  • Avionics
  • Vetronics
  • Cyber
  • Networking
  • Others

Pharmaceutical By Platform (USD Million, 2025-2035)

  • Land
  • Airborne
  • Marine
  • Space

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035